EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/eyepoints-late-stage-eye-drug-trials-continue-after-safety-2026a1000fnx?src=rss
Author :
Publish date : 2026-05-14 13:50:00
Copyright for syndicated content belongs to the linked Source.
